BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Azithromycin

A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

1.0k+ PubMed studies analyzed · 590 RCTs · Evidence Score: 78.3

Research Domains

Azithromycin has been studied across 11 research domains including 🫁 Respiratory, 😴 Sleep, 🔬 Inflammation, 🦠 Gut & Microbiome, 🛡️ Immunity. The primary research focus is 🫁 Respiratory with 17% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Azithromycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Diphenhydramine
4 shared targets
Propanil
3 shared targets
Farnesol
3 shared targets
Butaclamol
2 shared targets
Sulfathiazole
2 shared targets
pyrrolnitrin
2 shared targets
Itraconazole
3 shared targets
Methylnitronitrosoguanidine
2 shared targets
Robenidine
2 shared targets
Ethanolamine
2 shared targets
Loading evidence profile...

This evidence profile for Azithromycin is generated deterministically from 1,000 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.